Thermo Fisher Bioproduction Insights

  1. Rapid Selection Of High-Performance CHO Basal And Feed Media 5/5/2026

    A CHO-S bispecific antibody program needed a better basal and feed media combination. Learn how the screening of 180 conditions in 12 weeks identified one that delivered 38% higher titers.

  2. Achieving High Cell Purity With The CTS DynaCellect Magnetic Separation System 4/21/2026

    Learn how closed-system automation, combined with expert technical guidance and protocol optimization, turned a persistent manufacturing bottleneck into a reliable, scalable process.

  3. Anticoagulant Selection Influences T Cell Purity And Yield In Whole Blood Isolation 4/21/2026

    Lithium heparin reduces T cell purity to below 50% and spikes CD15+ contamination in whole blood workflows. See which anticoagulants consistently deliver above 90% CD3+ purity.

  4. Scale Up Or Scale Out? Choosing An Adherent Cell Culture Platform 4/21/2026

    Facility space costs up to $1,000/sq ft and planning timelines stretch 18 months, making your adherent cell culture platform choice one of the highest-stakes decisions in vaccine manufacturing scale-up.

  5. How Can Bioprocessing Professionals Evolve Their Manufacturing For Greater Flexibility And Efficiency? 4/21/2026

    Manufacturing flexibility is now a competitive differentiator. Here's how single-use technologies are reshaping bioprocessing facility design, scalability, and sustainability strategy.

  6. 3 Innovations For Reducing Risk In Continuous Downstream Bioprocessing 4/21/2026

    Batch-to-continuous transitions in downstream bioprocessing carry real risks. Here's how advanced analytics, smarter buffer strategies, and single-use systems are changing that calculus.

  7. What To Look For In A Cell Culture Media Supplier 4/17/2026

    Choosing a cell culture media supplier is crucial in biopharmaceutical manufacturing. Explore five key factors to take into account when choosing a supplier and evaluating their capabilities.

  8. Criteria For Effective Bioprocess Scale-Up 3/25/2026

    Discover four essential bioprocess scale-up criteria and how each balances hydrodynamics, shear, and mass transfer across manufacturing scales.

  9. Demonstrating Bioprocess Scalability Through Platform Consistency 3/25/2026

    Explore how a unified bioreactor design enables consistent process performance from bench to production, minimizing scale-up risk while maintaining cell growth and yield.

  10. How Predictive Algorithms Will Redefine Cell Culture Media Development 3/25/2026

    Discover how predictive modeling and AI are reshaping cell culture media development in biopharmaceutical manufacturing — accelerating timelines and enabling smarter, data-driven formulation strategies.